Q4 2025 · 13F-HR
Sand Grove Capital Management LLPholdings as filed
Filed 2026-02-17 · accession 0001665077-26-000003
$295.0M
Reported value
12
Positions
2025-12-31
Period end
The Brief · Sand Grove Capital Management LLP · Q4 2025
AI · grounded in 13F
Sand Grove Capital Management LLP initiated a new position in TXNM valued at $35.1M. The fund also established new stakes in WBD for $29.3M and EA for $28.5M. Additional new positions include HO1 at $28.2M and NSC at $24.5M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 69349H107 | TXNM | TXNM ENERGY INC | $35.1M | 11.9% | 596,592 | Common | SOLE |
| 934423104 | WBD | WARNER BROS DISCOVERY INC | $29.3M | 9.94% | 1,017,144 | Common | SOLE |
| 285512109 | EA | ELECTRONIC ARTS INC | $28.5M | 9.67% | 139,595 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $28.2M | 9.54% | 377,962 | Common | SOLE |
| 655844108 | NSC | NORFOLK SOUTHN CORP | $24.5M | 8.30% | 84,786 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $23.9M | 8.11% | 331,605 | Common | SOLE |
| 268158201 | DVAX | DYNAVAX TECHNOLOGIES CORP | $23.5M | 7.97% | 1,528,853 | Common | SOLE |
| 03152W109 | AM6 | AMICUS THERAPEUTICS INC | $23.5M | 7.95% | 1,647,030 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $23.2M | 7.88% | 228,799 | Common | SOLE |
| 49177J102 | KVUE | KENVUE INC | $21.9M | 7.43% | 1,270,766 | Common | SOLE |
| 171757206 | CDTX | CIDARA THERAPEUTICS INC | $17.9M | 6.05% | 80,821 | Common | SOLE |
| G0750C108 | AXTA | AXALTA COATING SYS LTD | $15.5M | 5.25% | 479,281 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.